Emerging from stealth, the company is debuting NEXUS, a Large Tabular Model (LTM) designed to treat business data not as a ...

Emerging from stealth, the company is debuting NEXUS, a Large Tabular Model (LTM) designed to treat business data not as a simple sequence of words, but as a complex web of non-linear relationships.

A few decades ago, a Super Bowl ad was the entirety of the marketing event. Apple’s classic ad from the 1984 Super Bowl was ...

Discover how researchers are overcoming the limitations of the undruggable target in drug discovery using novel approaches ...

The problem isn’t tools or data volume. It’s architectures, decision cycles, and how teams are built to respond.

N2OFF, Inc. (NASDAQ: NITO) ('N2OFF” and the 'Company”), a drug discovery company that is also investing in solar energy ...

A trial focused on whether Meta misrepresented the safety of its platforms when it comes to the dangers of child sexual ...

Exponent, Inc. (NASDAQ:EXPO) Q4 2025 Earnings Call Transcript February 5, 2026 Exponent, Inc. beats earnings expectations.

Altimmune, Inc. closed a $75 million direct offering to fund Phase 3 pemvidutide trials for MASH. Learn more about ALT stock ...

Q1 2026 Management View CEO Joakim Weidemanis opened by noting "Johnson Controls enters 2026 with a solid foundation and more ...

Advertisers aim to tailor ads to individual viewers to drive clicks, and while bespoke creatives for each person are currently impractical, new research suggests AI-generated imagery could soon be ...

Experts say live sports consistently dominates short-term reach on OTT platforms, followed by mass-appeal general ...